Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fennec Pharmaceuticals (FENC) Total Debt: 2011-2022

Historic Total Debt for Fennec Pharmaceuticals (FENC) over the last 8 years, with Sep 2022 value amounting to $25.0 million.

  • Fennec Pharmaceuticals' Total Debt was N/A to $25.0 million in Q3 2022 from the same period last year, while for Sep 2022 it was $25.0 million, marking a year-over-year change of. This contributed to the annual value of $167.0 million for FY2017, which is 505960.61% up from last year.
  • As of Q3 2022, Fennec Pharmaceuticals' Total Debt stood at $25.0 million, which was up 400.00% from $5.0 million recorded in Q2 2022.
  • Over the past 5 years, Fennec Pharmaceuticals' Total Debt peaked at $25.0 million during Q3 2022, and registered a low of $5.0 million during Q1 2022.
  • For the 1-year period, Fennec Pharmaceuticals' Total Debt averaged around $11.7 million, with its median value being $5.0 million (2022).